2 ms·
Yes, $1000 is a lot of money for that test. No, it is not incredibly useful. We're in a period of time when DNA testing is mainly for early adopters. However, t
by rms 19y ago
Yes, $1000 is a lot of money for that test. No, it is not incredibly useful. We're in a period of time when DNA testing is mainly for early adopters. However, the Moore's Law equivalent for DNA sequencing blows away the Moore's Law for transistors: every year genetic sequencing has become cheaper by tenfold.
23andme's disease risk indicators aren't overly meaningful, because they only test for a few SNPs and true disease risk is made up of many SNPs and multi nucleotide mutations and deletions, as well as levels of miRNA expression. Many of the mutations are only studied in caucasians. For now, most genetic tests are interesting rather than explicitly useful. Five or seven years from now, after Google's 100,000 genome project is complete and you can get a whole genome test for $1000, genetic testing will be very useful. Let's just hope that the results of that study are completely public.
- tlrobinson 19y agoIs 23andMe's test for HIV resistance the same gene as your startup tests for?
- rms 19y agoThat would make sense, though I thought they only tested for single nucleotide polymorphisms and the HIV mutation in question is a 32 base pair deletion.